Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 101Lung Neoplasms 41Neoplasms 13Neoplasm Metastasis 11Colorectal Neoplasms 8Parkinson Disease 4, Autosomal Dominant Lewy Body 6Pancreatic Neoplasms 5Mesothelioma, Malignant 5Mesothelioma 5Carcinoma 5Meningeal Carcinomatosis 4Melanoma 4Colonic Neoplasms 4Advanced Solid Tumors 4Rectal Neoplasms 3Ovarian Neoplasms 3Lung Diseases 3Carcinoma, Bronchogenic 3Adenocarcinoma 3Uterine Cervical Neoplasms 2Thoracic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Non-squamous Non-small Cell Lung Cancer 2Non-Squamous Non-small Cell Lung Cancer 2Non-Small Cell Lung Cancer Metastatic 2Non Small Cell Lung Carcinoma NSCLC 2Neoplasms by Site 2

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 3Cisplatin 2tislelizumab 1radium Ra 223 dichloride 1peposertib 1encorafenib 1cabozantinib 1binimetinib 1avelumab 1alovudine 1X-Rays 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Propranolol 1Platinum Compounds 1Platinum 1Pemetrexed 1Nivolumab 1Laparoscopy 1Ipilimumab 1Gemcitabine 1Conversion to Open Surgery 1Control Groups 1Carboplatin 1CTLA-4 Antigen 1Axitinib 1Androgen Antagonists 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × Pemetrexed × 90 days × Clear all
NCT07538193 2026-04-20

Iparomlimab and Tuvonralimab Plus Chemotherapy Before Surgery for Stage III Lung Cancer

Tang-Du Hospital

Phase NA Not yet recruiting
28 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡